EDITORIAL SECTION

Articles

Ethical Sourcing in Pharma: Top Strategies for Sustainable Supply Chains in 2026

Pharmaceutical business is moving into a decisive decade in which ethical sourcing has ceased being a corporate value of goodwill and has become a strategic need Pharma ethical sourcing is closely connected to business continuity regulatory compliance environmental stewardship and brand trust in With supply chains that are increasingly global fragmented and vulnerable to geopolitical climatic and...

How to Mitigate Operational Risks in the Pharma Industry?

The operation of the pharmaceutical industry has significant risks with the most probable being operational risks These risks include supply chain interruption regulatory non compliance product defects technological disruption The development of strategies to avoid compromise in operations remains paramount not only in protecting the customers from harm or receiving

The Evolving Role of AI in Pharmaceutical Commercial Strategy

For most of the past decade the pharmaceutical industry told its artificial intelligence story from the laboratory bench Molecule generation protein structure prediction and trial simulation captured the headlines and the capital Yet the economics of this industry have never been settled in discovery alone

Smarter, Faster, Cheaper: The Quiet Revolution in Pharma's First Half of 2026

If you took a step back to look at the pharmaceutical industry during the first six months of one thing became obvious very quickly The old rules of global drug manufacturing were quietly rewritten For decades major lowcost production centers were viewed mostly as highvolume factories for basic

Pharma Email Marketing Europe: Personalized Campaigns for C-Suite Leads

The pharmaceutical industry is a very competitive industry and to reach the decisionmakers a focused and strategic marketing strategy is necessary Conventional marketing is not often precise enough to reach executives that drive buying alliances and strategic relationships Here the pharma email marketing has come to play as a potent instrument of relationship establishment with the key stakeholder...

Biosimilars in Europe: Expanding Access and Reducing Costs

The use of biosimilars as a part of modern health care systems is also fairly important especially in the context of the European Union as they can enhance the availability of the required treatments and reduce the costs of the health care sector As biologic medicines are recognized as firstline treatments for critical illnesses such as cancer autoimmune diseases and rheumatoid arthritis biosimila...

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG

PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys